How does fusion with albumin prolong the half-life of albutrepenonacog alfa?

Albutrepenonacog alfa is fused with recombinant albumin, a natural, inert plasma carrier protein with an approximately 20-day half-life, prolonging its half-life and systemic exposure; the fusion remains intact in circulation until factor IX activation cleaves off albumin.